Lumos Diagnostics provides rapid, cost-effective point of care (POC) tests for infectious disease and antimicrobial stewardship. The company’s innovative and patented FebriDx® test is a 10-minute POC test to differentiate bacterial from viral acute respiratory infection including COVID-19 from fingerstick blood. FebriDx can reduce GP workload with a Nurse/Health Care professional led pathway enabling GP’s more time to concentrate on their more complex patients. In a GP study FebriDx was shown to improve clinical management in 48% of patients whilst safely reducing inappropriate antibiotic treatment by 80%. FebriDx can benefit GP’s, Urgent Care and Community Pharmacies for management of acute respiratory infections including sinusitis, bronchitis, influenza pneumonia and COVID-19.